Research evidence suggests that psoriasis, a chronic inflammatory immune-mediated disorder affecting 3% of individuals, or approximately 7.5 million people from the United States, is not an isolated pathology of the skin, but a systemic condition involving multiple organs and systems, with bacteria playing a central role.
According to the latest research, pathogenic Staphylococcus aureus is the driving force behind a chronic state of dysbiosis in 9 out of 10 eczema patoients.
Skin allergies and conditions, such as atopic dermatitis, psoriasis, and eczema, are inflammatory conditions all caused by a combination of immune activation, environmental factors, genetics, bacteria, and stress.
In 2003, the FDA approved colloidal oatmeal as an over-the-counter drug ingredient. It is classified as a skin protectant which temporarily protects and helps relieve minor skin irritations and itching due to eczema and rashes.